David Y. Chen
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 5%
Papers in
-
- Epigenetics and DNA Methylation 5
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- Eric R. Fearon (1 shared paper)Karen M. Hajra (1 shared paper)Kunxin Luo (1 shared paper)Eric Martens (1 shared paper)S. Zhou (1 shared paper)Qiang Zhou (1 shared paper)Weiru Wang (1 shared paper)Shannon L. Stroschein (1 shared paper)
- Journals
- Cancer Research (5 papers)Proceedings of the National Academy of Sciences (4 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)The Journal of Urology (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)
- Partner nations
- United StatesCanadaChina
In The Last Decade
David Y. Chen
58 papers receiving 2.7k citations
David Y. Chen's Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 827
- Cancer Research 386
- Molecular Biology 1.6k
- Hematology 142
- Neurology 164
Countries citing papers authored by David Y. Chen
This map shows the geographic impact of David Y. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Y. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Y. Chen more than expected).
Fields of papers citing papers by David Y. Chen
This network shows the impact of papers produced by David Y. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Y. Chen. The network helps show where David Y. Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Y. Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The SLUG zinc-finger protein represses E-cadherin in breast cancer. Hit paper breakdown → | 2002 | 859 |
| 2 | 1999 | 379 | |
| 3 | 2005 | 222 | |
| 4 | T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma Hit paper breakdown → | 2022 | 198 |
| 5 | 2006 | 132 | |
| 6 | 2019 | 131 | |
| 7 | 2009 | 95 | |
| 8 | 2000 | 88 | |
| 9 | 2016 | 73 | |
| 10 | 2010 | 41 | |
| 11 | 2006 | 40 | |
| 12 | 2011 | 35 | |
| 13 | 2009 | 33 | |
| 14 | 2021 | 33 | |
| 15 | 2010 | 29 | |
| 16 | Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A1C in an automated ion-exchange HPLC method. | 1998 | 29 |
| 17 | 2005 | 27 | |
| 18 | 2020 | 26 | |
| 19 | 2014 | 23 | |
| 20 | 2016 | 22 |
About David Y. Chen
David Y. Chen is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Genetics, having authored 63 papers that have together received 2.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), CAR-T cell therapy research (7 papers), Acute Myeloid Leukemia Research (6 papers), Epigenetics and DNA Methylation (5 papers), Virus-based gene therapy research (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Renal cell carcinoma treatment (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Oncology (827 citations), Cancer Research (386 citations), Molecular Biology (1.6k citations), Hematology (142 citations) and Neurology (164 citations). David Y. Chen has collaborated with scholars based in United States, Canada and China. Frequent co-authors include Eric R. Fearon, Karen M. Hajra, Kunxin Luo, Eric Martens, S. Zhou, Qiang Zhou, Weiru Wang, Shannon L. Stroschein, Yijun Yi and David H. Gutmann. Their work appears in journals such as Cancer Research, Proceedings of the National Academy of Sciences, International Journal of Radiation Oncology*Biology*Physics, The Journal of Urology and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.